Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Jul 11, 2023

SELL
$63.71 - $70.74 $74,795 - $83,048
-1,174 Reduced 26.72%
3,219 $205,000
Q1 2023

Apr 14, 2023

SELL
$65.71 - $74.53 $9,725 - $11,030
-148 Reduced 3.26%
4,393 $304,000
Q4 2022

Feb 09, 2023

BUY
$68.48 - $81.09 $94,776 - $112,228
1,384 Added 43.84%
4,541 $326,000
Q3 2022

Nov 14, 2022

BUY
$0.13 - $76.84 $410 - $242,583
3,157 New
3,157 $224,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $126B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Capital Advisors Wealth Management, LLC Portfolio

Follow Capital Advisors Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Advisors Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Capital Advisors Wealth Management, LLC with notifications on news.